580 related articles for article (PubMed ID: 15489350)
21. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
22. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation.
Peng T; Orsborn KI; Orbach MJ; Galgiani JN
J Infect Dis; 1999 Feb; 179(2):518-21. PubMed ID: 9878042
[TBL] [Abstract][Full Text] [Related]
23. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
24. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.
Kirkland TN; Finley F; Orsborn KI; Galgiani JN
Infect Immun; 1998 Aug; 66(8):3519-22. PubMed ID: 9673228
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
27. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
28. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
29. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
[TBL] [Abstract][Full Text] [Related]
30. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
Lecara G; Cox RA; Simpson RB
Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
[TBL] [Abstract][Full Text] [Related]
31. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
32. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
33. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
34. Multivalent recombinant protein vaccine against coccidioidomycosis.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Oct; 74(10):5802-13. PubMed ID: 16988258
[TBL] [Abstract][Full Text] [Related]
35. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination.
Galgiani JN; Sun SH; Dugger KO; Ampel NM; Grace GG; Harrison J; Wieden MA
Infect Immun; 1992 Jul; 60(7):2627-35. PubMed ID: 1612732
[TBL] [Abstract][Full Text] [Related]
36. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
37. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
38. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
39. Identification of a protective antigen of Coccidioides immitis by expression library immunization.
Ivey FD; Magee DM; Woitaske MD; Johnston SA; Cox RA
Vaccine; 2003 Oct; 21(27-30):4359-67. PubMed ID: 14505918
[TBL] [Abstract][Full Text] [Related]
40. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]